Reveals lipid-lowering effects of a red yeast rice complex in hyperlipidemic hamsters, suggesting potential utility as a functional food supplement.
Hypercholesterolemia is a significant risk factor for cardiovascular disease. Microbial metabolites such as red yeast rice and nattokinase, as well as flavonoids and polyphenols from plants like bergamot and grapes, have shown potential in lipid regulation. This study aimed to evaluate the lipid-regulating effects of a red yeast rice complex (RYRC) supplement containing microbial metabolites and plant extracts. In this study, hyperlipidemia was induced in Syrian hamsters using a high-cholesterol diet (HCD), followed by intervention with RYRC at doses of 0, 123.3, 246.7, and 616.7 mg/kg (n=9 per group) for six weeks. Lipid and cholesterol levels in the blood, liver, and feces were analyzed post-intervention. The results demonstrated that, compared to the HCD control group, RYRC supplementation significantly reduced serum TG, TC, LDL-C, and LDL-C/HDL-C ratio while increasing the HDL-C/TC ratio. Additionally, hepatic TG and TC levels were significantly reduced, and fecal TG and TC excretion were significantly increased. These findings suggest that RYRC regulates blood lipids by reducing cholesterol accumulation in the blood and liver and enhancing cholesterol excretion via feces. RYRC shows promise as a functional food supplement for lipid regulation.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: